Status:
COMPLETED
Cephalosporin Hypersensitivity
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Drug Hypersensitivity
Eligibility:
All Genders
10+ years
Brief Summary
Background : Although the hypersensitivity reactions to cephalosporins have been recently a more focused subject, studies on the cephalosporin as an allergen are significantly less frequent that thos...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- \- Patients with one or more ST and DPT tests to cephalosporins
- Exclusion criteria:
- \- Patients refusing to take part in the study
Exclusion
Key Trial Info
Start Date :
January 30 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2020
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04421638
Start Date
January 30 2020
End Date
June 1 2020
Last Update
June 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295